Christopher R Mueller (Christopher Mueller)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Positive Breast Cancer

Estrogen Receptor

Radical Prostatectomy

Top Venues

Clinical epigenetics

NPJ precision oncology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Katrina Cristall, Francois-Clement Bidard, Jean-Yves Pierga, Michael J Rauh, Tatiana Popova, Clara Sebbag, Olivier Lantz, Marc-Henri Stern, Christopher R Mueller
A DNA methylation-based liquid biopsy for triple-negative breast cancer. NPJ precision oncology 5 (1) (2021)
Florence Coussy, Rania El-Botty, Sophie Château-Joubert, Ahmed Dahmani, Elodie Montaudon, Sophie Leboucher, Ludivine Morisset, Pierre Painsec, Laura Sourd, Léa Huguet, Fariba Nemati, Jean-Luc Servely, Thibaut Larcher, Sophie Vacher, Adrien Briaux, Cécile Reyes, Philippe La Rosa, Georges Lucotte, Tatiana Popova, Pierre Foidart, Nor Eddine Sounni, Agnès Noel, Didier Decaudin, Laëtitia Furhmann, Anne Salomon, Fabien Reyal, Christopher R Mueller, Petra Ter Brugge, Jos Jonkers, Marie-France Poupon, Marc-Henri Stern, Ivan Bièche, Yves Pommier, Elisabetta Marangoni
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. Science translational medicine 12 (531) (2021)
Jacob J K Carson, Michael A Di Lena, David M Berman, D Robert Siemens, Christopher R Mueller
Development and initial clinical correlation of a DNA methylation-based blood test for prostate cancer. The Prostate 80 (12) (2020)
Hilary Snider, Brithica Villavarajan, Yingwei Peng, Lois E Shepherd, Andrew C Robinson, Christopher R Mueller
Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer. Clinical epigenetics 11 (1) (2019)